BACKGROUND AND OBJECTIVES: In the EORTC ALL-3 trial, the efficacy of allogeneic transplantation was compared with that of autologous marrow transplantation and maintenance chemotherapy in patients
Figures & Tables
Article Information
Vol. 89 No. 7 (2004): July, 2004 : Articles
Published
2004-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
Article Usage
Online Views
207
PDF Downloads
103
Statistics from Altmetric.com
No Data
How to Cite
1.
B Labar, S Suciu, R Zittoun, P Muus, JP Marie, G Fillet, M Peetermans, P Stryckmans, R Willemze, W Feremans, B Jaksic, JH Bourhis, JP Burghouts, T de Witte, EORTC Leukemia Group. Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin’s lymphoma for patients <or=50 years old in first complete remission: results of the EORTC ALL-3 trial. Haematologica 2004;89(7):809-817; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
